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Abstract Assessment of stent strut coverage by
optical coherence tomography (OCT) is not standard-
ized. The methodology most commonly used is based
on a visual binary qualitative assessment (strut cov-
ered or not). However, the influence of magnification
(zoom setting) to the inter- and intra-observer agree-
ments has not yet been evaluated. Aim of our study
was therefore to evaluate the agreements of this
approach, taking into account various zoom settings.
126 struts from 10 selected frames were independently
evaluated by four observers using a stepwise approach
increasing the zoom setting as following: (1) full view
of the lumen (FV), (2) half view of the lumen (HV) and
(3) a quarter view of the lumen (QV). Intra- and inter-
observer agreements (j) were assessed. The rate of
uncoverage was determined for each strut as the
number of times it was defined as uncovered divided
by the total number of observations (maximum
12 = 3 zoom settings 9 4 analysts) and expressed
as percentage. The inter-observer j values (mean
[range]) were 0.32 [0.07–0.63], 0.40 [0.18–0.69] and
0.33 [0.09–0.6], within FV, HV and QV respectively.
The intra-observer j values were 0.60 [0.50–0.70],
0.75 [0.75–0.76] and 0.60 [0.50–0.70], within FV, HV
and QV respectively. By increasing zoom setting the j
value of intra-observer agreement was 0.74
[0.58–0.83] (from FV to HV), 0.70 [0.56–0.83] (from
HV to QV) and 0.70 [0.37–0.86] (from FV to QV).
Overall, the rate of uncoverage was 15.5%
[8.3–100%]. The OCT qualitative evaluation of strut
coverage has wide inter and intra-observer agreements
and is dependent of the zoom setting used during the
analysis. A more reproducible approach would be
needed to eventually increase the probability to link
uncovered struts with clinical events.
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Introduction
Optical coherence tomography (OCT) is a light-based
imaging modality that can provide in vivo high-
resolution images of coronary stents, with detailed
information about struts apposition and tissue cover-
age [1]. Pathological studies have suggested that the
absence of stent strut coverage due to delayed vascular
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healing and the persistence of fibrin may be the most
important determinants of late stent thrombosis,
together with lesion and procedure-related settings
[2, 3]. For this reason, coverage at strut-level analysis
by OCT is the most common surrogate endpoint in
OCT studies, providing a measurable variable for the
comparison between different stents and being also an
important parameter for the approval of new drug
eluting stents by regulatory agencies [4].
The inter- and intra-observer reproducibility for
strut count, strut apposition and quantitative strut
tissue coverage measurement (e.g. neointima thick-
ness) has been shown to be good [5, 6]. However, strut
coverage evaluation is not standardized. The most
commonly used approach is the visual qualitative
assessment, evaluating strut coverage as a binary
variable (covered or not covered). Moreover, inde-
pendently from the methodology used, the zoom
setting used for magnifying the OCT images may
influence the assessment and thereby the reproduc-
ibility of strut coverage assessment.
The objective of the present study was to revise this
qualitative approach for the assessment of strut
coverage by measuring the inter- and intra-observer
agreement and evaluating the influence of various
zoom settings.
Methods
Study population
From our OCT database all patients, who received an
OCT pullback at 6 months after stent implantation,
were selected. After an initial quality check, an
independent analyst (not involved in the assessment
of coverage) randomly selected 10 frames from the
OCT pullbacks identifying 126 struts, according to the
following definitions:
• Highly reflective surface with cast dorsal and
radial shadows;
• Highly reflective surface without dorsal
shadowing.
The stent implanted was Resolute Endeavor in all
the frames analyzed. Struts were termed ‘‘covered’’ by
OCT if tissue could be identified above the struts, as
previously defined [7].
OCT acquisition
The OCT acquisition was performed using a commer-
cially available system for intracoronary imaging
(C7XR Fourier-Domain System; LightLab Imaging,
Westford, Massachusetts). Pullback was performed
during continuous injection of contrast medium
(3 mL/s, Iodixanol 370, Visipaque, GE Health Care,
Cork, Ireland) through the guide catheter with an
injection pump. The automated pullback rate was
20 mm/s and the frame rate was 100 images/s.
Qualitative evaluation of strut coverage
Four independent and expert observers separately
analyzed the selected frames in order to qualify the
coverage of the struts, previously defined, as a qualita-
tive binary variable (yes/no). In particular, two analysts
(Obs 1 and Obs 2) were interventional cardiologists with
wide expertise in OCT evaluation; the remaining two
(Obs 3 and Obs 4) were senior OCT CoreLab analysts,
without experience in cardiology practice. All of them
repeated the analysis with three different zoom settings
1 week later at each step in order to estimate the intra-
observer agreement, related to the zoom setting (Fig. 1).
Two of the analysts repeated all the analyses 4 weeks
later with the same stepwise protocol in order to estimate
also the intra-observer agreement within the same zoom
setting. The predefined zoom settings used were: full
view of the lumen, half view of the lumen and quarter
view of the lumen (Fig. 2). Each strut was then
evaluated 12 times (four different observers with three
different zoom settings).
For the purpose of the study, the rate of uncoverage
of each strut was determined according to the follow-
ing formula:
100  Number of times a strut isdefined as uncovered
Total number of observation
Statistical analysis
The agreement in the number of struts evaluated as
covered was estimated by the kappa test for agreement.
The kappa values are presented as mean and range
within the various zoom setting. According to previous
publications: B0 indicates poor agreement, 0–0.20
indicates slight agreement, 0.21–0.40 indicates fair
agreement, 0.41–0.60 indicates moderate agreement,
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0.61–0.80 indicates good agreement, and 0.81–1.0
indicates excellent agreement [8, 9]. Wilcoxon paired
test was used to compare the number of struts assessed as
covered between the various zoom factors. Comparison
between groups was performed by Mann–Whitney test.
Data were analyzed with SPSS version 16.0 software
(SPSS Inc., Chicago, IL).
Results
Inter-observer agreement within the same zoom
setting
Table 1 reports the inter-observer agreements accord-
ing to the various zoom settings used. The j values
Fig. 1 Flow-chart of the study analysis
Fig. 2 Examples of the various zoom settings used in the analysis
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were 0.32 [0.07–0.63], 0.40 [0.18–0.69] and 0.33
[0.09–0.65], from the full view of the lumen, through
half view up to quarter view of the lumen, respec-
tively. Out of 126 struts, the average number of the
struts evaluated as uncovered by the analysts was 21.5
[range: 3–50] using the full view of the lumen, 20.2
[7–46] with half view of the lumen and 17.2 [3–42]
with quarter view of the lumen.
Overall, there was on average a progressive
decrease in the struts detected uncovered going from
full to half view of the lumen (-5.8%; p = 0.275),
from full to quarter view of the lumen (-14%;
p = 0.001), and from half to quarter view of the lumen
(-17%; p = 0.018).
Intra-observer agreement changing the zoom
setting
Increasing the zoom setting from full to half view of
the lumen, the intra-observer agreement (k-value) was
0.74 [0.58–0.83], while from half to quarter view of
the lumen it was 0.70 [0.56–0.83] and from full to
quarter view of the lumen 0.70 [0.37–0.86] (Table 2).
In particular, the intra-observer agreement was higher
within Obs 3 and 4 (senior OCT CoreLab analysts)
than within Obs 1 and 2 (interventional cardiologists
with wide expertise in OCT evaluation) (0.82
[0.76–0.86] vs. 0.61 [0.37–0.76]; p = 0.002).
Intra-observer agreement within the same zoom
setting
Two analysts have assessed the intra-observer agree-
ment within the same zoom setting. Using full view of
the lumen the average k-value of agreement for each
observer was 0.60 (0.70 and 0.50 for the two
observers, respectively), using half view of the lumen
it was 0.75 (0.76 and 0.75 for the two observers,
respectively) and using quarter view of the lumen 0.60
(0.50 and 0.70 for the two observers, respectively).
Rate of uncoverage of the struts
Overall, the rate of uncoverage for each strut was
15.5% [8.3–100%]. Within full view of the lumen it
was 16.9% [25–100%], half view 16.0% [25–100%],
quarter view 13.6% [25–100%] (Fig. 3).
Discussion
Our analysis demonstrates a wide inter- and intra-
observer agreement for uncovered struts evaluated
visually by OCT, which is highly dependent of the
zoom setting used in the analysis.
Vascular healing of metallic stent has been exten-
sively studied by anatomo-pathologists, as the delay-
ing of this process has been related to the occurrence of
Table 1 Inter-observer agreement within a same zoom setting
Observer 1 Observer 2 Observer 3 Observer 4
Full view of the lumen
Observer 1 0.40 0.07 0.20
Observer 2 0.40 0.25 0.63
Observer 3 0.07 0.25 0.41
Observer 4 0.20 0.63 0.41
Half view of the lumen
Observer 1 0.69 0.18 0.45
Observer 2 0.69 0.18 0.45
Observer 3 0.18 0.18 0.47
Observer 4 0.45 0.45 0.47
Quarter view of the lumen
Observer 1 0.65 0.09 0.25
Observer 2 0.65 0.18 0.37
Observer 3 0.09 0.18 0.47
Observer 4 0.25 0.37 0.47
J value are reported
Table 2 Intra-observer agreement, according to the zoom
setting
From lumen to half view of the lumen
1st Observer 0.58
2nd Observer 0.76
3rd Observer 0.83
4th Observer 0.80
From lumen to quarter view of the lumen
1st Observer 0.65
2nd Observer 0.56
3rd Observer 0.83
4th Observer 0.76
From half to quarter view of the lumen
1st Observer 0.37
2nd Observer 0.75
3rd Observer 0.86
4th Observer 0.85
J value are reported
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very late stent thrombosis [2]. In vivo, OCT is highly
suited for the evaluation of strut coverage due to its
high resolution and image quality [10]. Assessment of
stent strut coverage, however, is not standardized and
a quantitative or qualitative approach can be used. In
the first methodology, struts coverage is evaluated
through quantification of tissue coverage area: the
operator manually traced the stent and lumen area,
deriving the tissue coverage area. Using this kind of
approach, a good intra- and inter-observer agreement
has been reported for the neointima thickness mea-
surement [5, 11, 12]. In a further step, in order to report
these data at strut level, a predefined threshold of neo-
intima thickness is used in a semi-quantitative fashion
to define a strut as covered [13, 14]. However, some
important concerns must be highlighted in the inter-
pretation of these results. The use of a threshold is
quite arbitrary and has some therein limitations, as it is
not standardized for different stent and even for the
same stent. In addition, Murata et al. comparing the
morphometric differences at the strut level between
OCT and histology have shown that the correlation
between these techniques is much dependent on the
amount of the neointima present. OCT seems to
correlate appropriately with histology only in either
the absence (\20 lm) or the presence ([100 lm) of
robust neointima. It should be also considered that the
strut blooming is about 37 lm in thickness and
extends bi-directionally toward and away from the
catheter light source, complicating the measurement
of low neointimal coverage (\20 lm) [15]. Of note is
that 10–20 lm represents the OCT resolution and that
the majority of the drug eluting stents report a
neointima thickness between 20 and 100 lm. For
these reasons, the choice of an arbitrary threshold
should be carefully considered. In addition, the zoom
setting used in the analysis, seldom reported in the
majority of the OCT-stent papers, is not standardized
and can further increase the variability of the
assessment.
Fig. 3 Example of the wide variability of the rate of
uncoverage, according to the various zoom settings used in
the analysis. Some struts are adjudicated by all the analysts as
uncovered, independently from the zoom setting (rate of
uncoverage 100%). Some struts have a probability to be defined
as uncovered from 8.3 to 83.3%
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The second and most used approach to evaluate the
strut coverage is a visual qualitative classification of
strut coverage as a binary variable (covered or not
covered) [16]. This qualitative assessment is some-
times performed at a distance interval different from
that used in the quantitative OCT measurement (e.g.
each frame vs. 0.33 mm interval) and no reproduc-
ibility is reported [17]. The zoom setting, of utmost
importance in this qualitative evaluation as compared
to the quantitative approach, is neither standardized
nor specified. In our analysis, we tested the agreement
of this approach in a Core Lab, using different zoom
settings. We demonstrated that the zoom setting is an
important bias and the range of intra-observer agree-
ment according to the zoom used is very wide: a same
strut can range from 0 to 25% probability to be
considered as uncovered, using different zoom. In
particular, moving from the first (lumen) to the second
zoom (half lumen), there was a slight decrease in the
number of the strut detected as uncovered. Increasing
further the zoom (quarter lumen), there was a signif-
icant decrease in the struts detected as uncovered.
Using the same zoom setting, the intra-observer
agreement was on average good, but with wide
variability. Although overall the inter and intra-
agreement was not high (e.g. close to 1), looking at
the various k-value per zoom factor the half view of
the lumen appeared as the zoom factor with a higher
reproducibility between and within the observers as
compared to the others and could be used as a
reference in future studies.
Of note is that in a careful evaluation of our results
two different kind of analysts can be identified: the
Core Lab analysts (Obs 3 and Obs 4) showed a good
intra-observer agreement changing the zoom setting,
compared to the interventional cardiologists with wide
experience in OCT evaluation (Obs 1 and Obs 2), who
exhibited a low agreement in their measurements
changing the zoom setting. This observation supports
the presence of a CoreLab for performing such
analysis, which should be blinded to the clinical
meaning of the measurements and only based on a
phenomenological description of strut coverage.
The poor agreement in qualitative assessment of
strut coverage raises some concerns about the clinical
interpretation of these findings. OCT was, indeed,
advocated as the gold standard to evaluate the
reliability of the degree of incomplete coverage,
identifying those patients at increased risk of late
stent thrombosis. Nevertheless, it is unable to distin-
guish between fibrin, giant cells, granulomatous
reaction and degree of endothelization and our results
could be considered as supportive of this limitation, as
each analysts thinks differently about the ‘‘status’’ of
coverage of each strut.
Limitations
A small number of frames have been analyzed in the
current study to allow multiple evaluations by the 4
different observers. The fact that the k-value could
improve by increasing the number of observation
should be acknowledged. Nevertheless, it is of note
that four different observers, who assessed the frames
up to 4 times, have been used in our analysis.
Conclusions
Qualitative evaluation of strut coverage by OCT has
wide inter and intra-observer agreements, extremely
dependent from the zoom setting used during the
analysis.
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